Impact of New LV Ejection Index in MR
The aim of this study was to identify whether a new composite echocardiographic marker of LV dilatation according to the quality of LV ejection may predict postoperative LVD and outcome in patients with primary MR.
Methods Population
Between January 1991 and December 2010, 335 patients who underwent mitral valve repair for severe chronic primary MR because of leaflet prolapse were studied (University Hospital of Amiens, Amiens, France). Patients underwent comprehensive preoperative (within 3 months before surgery) and postoperative (between 9 and 12 months after surgery) echocardiographic evaluation. The postoperative LV ejection fraction was not available in 29 patients.
Exclusion criteria were (1) MR caused by ischemic heart disease or dilated cardiomyopathy, rheumatic heart disease, active infective endocarditis, and congenital heart disease; (2) previous cardiac surgery; (3) concomitant aortic valve or aortic root surgery; (4) patients with history of myocardial infarction or recent acute coronary syndrome; and (5) patients (n=53, 16%) with missing preoperative LV ejection fraction, LV end-systolic diameter data, or LV outflow tract time-velocity integral (LVOT TVI ). These results are from a whole cohort of 278 patients, out of which the postoperative LV ejection fraction was available and assessed in 249 patients.
Baseline clinical characteristics, comorbidity, symptoms, and operative data were collected from patients' medical records. The Charlson index was calculated and used as comorbidity score. The standard EuroSCORE was calculated retrospectively for each patient using the calculator available online at http://www.euroscore. org. We obtained institutional review board authorization before conducting the study. The study was conducted in accordance with institutional policies, national legal requirements, and the revised Helsinki declaration.
Echocardiographic Measurements
Diagnoses of leaflet prolapse and flail leaflets were identified according to the recommended criteria. 13, 14 LV dimensions were assessed from parasternal long-axis views by 2D-guided M-mode using the leading edge methodology at end diastole and end systole. All LV dimension were indexed for body surface area. LV ejection fraction was estimated by the Simpson biplane method or, in a minority of cases, visually (<5%). Preoperative LVD was defined as LV ejection fraction <60% and postoperative LVD as ≤50%. The LVOT TVI was obtained using pulsed wave Doppler. Severity of MR was assessed by Doppler echocardiography, as recommended. 15 The LV ejection index was calculated as the following ratio:
End Points Study
End points of the study were postoperative overall mortality and cardiovascular mortality. During follow-up, patients were monitored by their personal general practitioners or cardiologists. The deaths were ascertained by review of medical records, clinical interviews, or by telephone calls to physicians, patients, and (when necessary) next of kin.
Statistical Analysis
The data are presented as mean±SD or percentages and absolute number. The distribution of continuous data was tested for normality using the Kolmogorov-Smirnov test and skewed variables were presented using median (25th and 75th percentiles). The population The relationship between postoperative LV ejection fraction and preoperative variables was assessed using Pearson or Spearman correlation. The multivariable relationship between LV ejection index and postoperative LVD was assessed using logistic regression. In addition, receiver operating characteristics curve was used to derive the best cutoff value to predict postoperative LVD using the Youden index.
Survival was estimated using Kaplan-Meier curves, and statistical difference between impaired and preserved preoperative LV ejection index group was assessed using log-rank test. Univariable and multivariable Cox proportional hazard regression analyses were performed to evaluate predictors of mortality, and hazard ratio (HR) and 95% of confidence interval (95% CI) were reported.
A P value of 0.05 was considered significant for all statistical tests. Data were analyzed with SPSS 17.0 (SPSS Inc, Chicago, IL).
Results
Among the 278 patients included in the study (age, 65±11 years; 70% of male), 249 have available postoperative LV ejection fraction and 26% (n=64) have developed postoperative LVD. Demographic, clinical, and preoperative echocardiographic data are reported in Tables 1 and 2 .
The LV ejection index ranged from 0.46 to 2.73 (mean, 1.23±0.38; median, 1.17). There was a weak correlation between preoperative LV ejection index and preoperative LV ejection fraction (r=−0.32; P<0.0001).
Postoperative LVD
Compared with patients without postoperative LVD (n=185), those with LVD (n=64) had significantly lower weight (P=0.04) and body mass index (P=0.002), and there was a trend for significant older age (P=0.075) and higher rate of renal failure (P=0.054; Table 1 ). There was no other significant difference between these 2 groups regarding demographic and clinical data, and risk scores. Compared with patients without postoperative LVD, the group with postoperative LVD had significant higher preoperative LV dimension (Table 2 ) and lower LV stroke volume (P=0.009) and LV ejection fraction (P=0.003). The LV ejection index was markedly and significantly higher in patients with postoperative LVD (1.47±0.39 versus 1.13±0.32, P<0.0001). Excluding patients with preoperative LV ejection fraction <60% from the analysis led to similar results than in the whole population (Table 3) .
Predictor of Postoperative LVD
The postoperative LV ejection fraction (available in n=249) was significantly correlated with preoperative LV size and function (Table 4) . Among all other possible ratios combining LV stroke volume or LVOT TVI and LV diameters (r≤0.25, P value from 0.15 for indexed LV stroke volume/LVOT TVI to <0.0001 for LV end-systolic diameter/LVOT TVI ) as well as single parameters (all r≤0.28, P value from 0.019 to 0.0001; Table  4 ), including body surface area indexation, the best correlation was reported with LV ejection index (r=−0.40; P<0.0001). There was a nonsignificant correlation between postoperative LV ejection fraction and age and weight (P=0.059 and P=0.06, respectively).
Focusing only on patients with preoperative LV ejection fraction ≥60% (n=222 from 249 available postoperative LV ejection fraction) resulted in similar findings except for indexed LV end-diastolic diameter and LV ejection fraction that were no longer significantly correlated with postoperative LV ejection fraction (Table 4) . In this subset, LV ejection index remained the best univariable predictor of postoperative LVD (r=−0.46; P<0.0001).
Using receiver operating characteristic curve analysis, LV ejection index showed good sensitivity and specificity in identifying postoperative LVD (area under the curve=0.75, cutoff value=1.13, sensitivity=0.80, and specificity=0.64). 
Impact of New LV Ejection Index in MR
The other ratios identified as predictor of LVD were LV endsystolic diameter/LVOT TVI ratio (area under the curve=0.74, cutoff value=2.35, sensitivity=0.64, and specificity=0.76) and LV end-systolic diameter/LV stroke volume ratio (area under the curve=0.69, cutoff value=0.74, sensitivity=0.52, and specificity=0.84).
On multivariable analysis, LV ejection index remained a significant independent predictor of postoperative LVD both considered as continuous variable or according to the threshold of 1.13, even after adjustment for preoperative age, sex, weight, LV end-systolic diameter, and LV ejection fraction (Table 5 ). In patients with preoperative LV ejection fraction ≥60%, the multivariable analysis also identified LV ejection index as an independent predictor of postoperative LVD.
Consistently, the LV end-systolic diameter/LVOT TVI ratio was also independently associated with postoperative LVD with similar predictive value (both χ 2 =42). See Figure I in the Data Supplement.
The presence of preoperative tricuspid regurgitation grade 3 or 4 (5%) and pulmonary hypertension (34%, ie, systolic pulmonary arterial pressure >50 mm Hg) was not associated with postoperative LVD, neither in univariable nor in multivariable analysis (all P>0.17) .
At the last available follow-up, 23 patients depicted recurrent grade 3+ or 4+ MR, resulting in MR recurrence rates of 6±1%, 9±2%, and 15±4% at 6, 12, and 15 years, respectively. There was no significant relationship between postoperative LVD and recurrent MR (P=0.152). During a mean postoperative follow-up of 10±4.6 years (median, 10 years [6-13 years]), 85 deaths occurred and 23 were from cardiovascular cause, resulting in overall survival of 86±2% at 6 years, 68±3% at 12 years, and 56±4% at 15 years, and in cardiovascular death-free survival of 96±1% at 6 years, 90±2% at 12 years, and 83±4% at 15 years. Patients with a LV ejection index >1.13 had significant higher rate of death (36% versus 24%; P=0.021) and cardiovascular death (12% versus 4%, P=0.011) than those with preserved LV ejection index (ie, >1.13).
The 15-year survival and cardiovascular death-free survival were significantly lower (P=0.017 and P=0.008, respectively) in patients with increased LV ejection index (ie, >1.13; Figure 1 ). Similar results were found when patients with preoperative LV ejection fraction <60% were excluded (Figure 2 ). In patients (n=225) with combined preserved preoperative LV ejection fraction (≥60%) and LV end-systolic diameter <45 mm, the 15-year survival 
Predictor of Long-Term Postoperative Mortality and Cardiovascular Mortality
Preoperative impaired LV ejection index was significantly associated with postoperative death and cardiovascular death, independently of age and sex (Table 6) . Further multivariable adjustments (model 1) for advanced New York Heart Association functional class, Charlson index, LV end-systolic dilatation, and impaired LV ejection fraction identified that preoperative LV ejection index (ie, >1.13) was an independent predictor of death (HR, 1.64; 95% CI, 1.02-2.64; P=0.039) and of cardiovascular death (HR, 3.27; 95% CI, 1.15-9.28; P=0.026). The addition of renal failure to the model 1 (Table  6 ) resulted in a significant association between preoperative 
024).
However, when compared with LV ejection index, the LV end-systolic diameter/LVOT TVI ratio, although significant, was less predictive of both mortality and cardiovascular mortality (model χ 2 : 30.9 versus 28.8 and model χ 2 : 14.9 versus 13.1, respectively). Moreover, the ratio of LV endsystolic diameter/LV stroke volume was not associated with mortality or cardiovascular mortality in univariable analysis 
Discussion
The results of this study show that in patients with primary MR undergoing mitral valve repair: (1) increased preoperative LV ejection index (ie, >1.13) is an independent predictor of postoperative LVD and (2) a powerful determinant of postoperative survival and cardiovascular mortality, even in those with preserved preoperative LV ejection fraction and without severe LV dilatation. In addition, the LV ejection index seems superior to other ratios combining LV stroke volume or LVOT TVI and LV diameter in the prediction of both postoperative LVD and survival. Nonetheless, the use of nonindexed LV end-systolic diameter in the calculation of LV ejection index (ie, >2.35) is also significantly associated with outcome and could be preferred in obese patients in whom LV indexation is not suitable.
LV Ejection Index
The LV ejection index is an easy-to-obtain surrogate marker of the impact of MR on both LV dilatation and LV systolic function (ie, ejection). With MR worsening and LV contractility impairment, the LVOT TVI may decreases. In parallel, LV volume overload, because of chronic MR, progressively lead to LV dilatation. Together, these harmful consequences of MR will be highlighted by a marked increase in LV ejection index. Of note, LVOT TVI and indexed LV end-systolic diameter are unrelated in our series (r=−0.08; P=0.21), suggesting that these 2 parameters independently reflect the impact of MR on ejection and dilatation, respectively. Consequently, the impact of MR on only 1 of these 2 components will be detected by LV ejection index, explaining, at least in part, its strong relationship with postoperative LV function and outcome. For a given indexed LV endsystolic diameter, reduced LV TVI will result in increased LV ejection index. Similarly, for a given LV TVI, progressive LV dilatation and increase in indexed LV end-systolic diameter will also produce increased LV ejection index. Our data showed almost similar prognostic value of nonindexed LV end-systolic diameter/LVOT TVI ratio. This suggests that in obese patients, in whom indexation may lead to erroneous conclusion, the use of nonindexed ratio could be an appropriate alternative.
LV Ejection Index Versus LV Ejection Fraction
In our series, despite significant, the relationship between LV ejection index and LV ejection fraction is notably weak. This may suggest that LV ejection index could be a good complementary parameter to LV ejection fraction for the risk stratification and the management of patients with primary MR. Although LV ejection fraction is a powerful determinant of poor prognosis 16 and an accurate marker of LV systolic dysfunction, 6 it often underestimates the degree of dysfunction in volume overload disease such as MR. Indeed, in patients with significant MR, LV ejection fraction if often normal or mildly reduced despite marked alteration of LV myocardial function, as suggested by recent series using speckle-tracking analysis. 9, 17 In addition, preserved LV ejection fraction ≥60% does not necessarily imply absence of risk of cardiac event.
9,17,18 LV ejection fraction is not a pure marker of myocardial contractility. It is also highly influenced by LV geometry, the loading conditions, and the MR severity. 19 Indeed, for a given level of contractility, a significant increase in LV preload, which is common in chronic MR, and a decrease in LV afterload will yield to higher LV ejection fraction. This mechanism may explain why LV ejection fraction is often preserved in patients with severe primary MR, despite myocardial impairment.
Hence, LV ejection fraction grossly underestimates the extent of myocardial impairment in patients with MR. In patients with primary MR, the LV ejection fraction is often maintained within normal range owing to increased preload and reduced afterload. However, following mitral valve repair, the preload and afterload are normalized and LV ejection fraction drops thereby revealing the existence of myocardial dysfunction, which was masked before surgery. 6 Furthermore, the LV ejection fraction may also be artificially maintained within normal range or close to normal range by the presence of the MR itself. 19 The LV ejection fraction is the result of LV stroke volume divided by LV end-diastolic volume. However, LV stroke volume is the sum of LV forward stroke volume ejected through the LV outflow tract+the regurgitant volume. Hence, when the regurgitant volume increases, LV ejection fraction may increase, although myocardial contractility and LV forward stroke volume may be reduced. This close relationship between MR and LV ejection fraction underlines the usefulness of complementary parameter, such as LV ejection index, which is free of the impact of MR in its measurement.
LV Ejection Index Versus LV Longitudinal Function Parameters
The LV longitudinal function assessment, derived from tissue Doppler imaging, was found to be associated with the severity of MR in a cohort of patients including a majority of preserved LV ejection fraction. 20 Nevertheless, this technique requires high frame rate, narrow sector images, high-quality recording, and is particularly time consuming. In addition, tissue Doppler imaging strain and strain rate-derived parameters remain highly angle dependent.
More recently, LV longitudinal function was also assessed in patients with MR using 2D speckle-tracking analysis, both at rest 9 and during exercise. 17 Although the quantification of LV global longitudinal strain seems appealing and clinically useful, owing to its relationship with outcome, it also remains time consuming and required high-quality images. Furthermore, the measurement of LV global longitudinal strain is geometry and load dependent. 11, 21 In opposition, LV ejection index is rapid to calculate and only requires measurement and images mandatory in routine echocardiographic examination.
Limitations
This study is retrospective, suggesting that all the results reported are limited by bias related to this design. The LV volumes were only available in a small sample of the studied population precluding subsequent analysis. In addition, the LV myocardial performance index, right ventricular, and diastolic function are lacking from our database. Furthermore, the postoperative LV ejection fraction was not available in 29 patients. Impact of New LV Ejection Index in MR Because of the period of inclusion, the LV longitudinal strain parameters were not available in this cohort. The direct comparison between these parameters and LV ejection index was, thus, not performed.
Quantitative assessment of severity of MR using the proximal flow convergence method was not systematically performed in the current cohort. Nevertheless, MR was quantified as grade 3+ or grade 4+ in all these patients considered for surgery using an echocardiographic multiparametric approach or LV angiography. The LV ejection index is subject to drawbacks that required to be mentioned. First, as indexed, LV end-systolic is used as numerator, all limitations related to this parameter (eg, load dependency, single dimensional) may also be apply to LV ejection index. In addition, LVOT TVI is also limited by angle dependency. Nevertheless, the close independent relationship reported between LV ejection index and postoperative outcome may suggest that these limitations do not depreciate the usefulness of this new parameter.
Conclusions
After mitral valve repair for primary MR because of mitral valve prolapse, the preoperative LV ejection index is a new and simple composite parameter of both LV dilatation/forward flow able to accurately predict postoperative LVD. In addition, increased LV ejection index (ie, >1.13) is strongly associated with reduced long-term survival and markedly increased risk of cardiac death, independently of symptom, comorbidity, and LV parameters currently used in guidelines (ie, LV ejection fraction and LV end-systolic diameter). Consequently, LV ejection index may be used as an accurate complementary parameter to stratify the risk and guide decision making in patients with primary MR. Prospective large study is, however, required to confirm these findings.
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